Value Sense
HIMS
Hims & Hers Health, Inc. (HIMS)
Last Price$40.7(9.8%)
Market Cap$9,261.6M
LTM EBITDA margin
4.9%
5Y avg
(22.0%)
Household & Personal Products industry median
11.5%
Stock quality & Intrinsic value
7/10
(0.5%) overvalued
HIMS
is (45.4%) overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Hims & Hers Health, Inc. EBITDA margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
HIMS
Consumer Defensive
Crunching data... Almost there!
Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
EBITDA margin
0.0%
(89.8%)
(9.5%)
(40.8%)
(11.6%)
(2.3%)
HIMS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for HIMS and see if it's the right time to invest.
Dive in

Hims & Hers Health, Inc. (HIMS) EBITDA margin comparison analysis

General

LTM EBITDA margin

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

Hims & Hers Health, Inc. logo
Hims & Hers Health, Inc.HIMS
4.9%
65.5%
(65.6%)
(2.7%)
Median Peer Set
17.4%
2.1%
(4.3%)
10.2%
The Procter & Gamble Company logo
The Procter & Gamble CompanyPG
27.6%
2.5%
3.8%
17.7%
Colgate-Palmolive Company logo
Colgate-Palmolive CompanyCL
24.7%
3.3%
27.0%
14.4%
Kenvue Inc. logo
Kenvue Inc.KVUE
20.5%
0.1%
(40.0%)
6.7%
Unilever PLC logo
Unilever PLCUL
20.0%
1.8%
(12.4%)
10.9%
Kimberly-Clark Corporation logo
Kimberly-Clark CorporationKMB
18.8%
(1.8%)
45.5%
12.7%
Church & Dwight Co., Inc. logo
Church & Dwight Co., Inc.CHD
16.0%
4.1%
(22.7%)
9.6%
The Clorox Company logo
The Clorox CompanyCLX
13.5%
(4.0%)
86.0%
3.9%
e.l.f. Beauty, Inc. logo
e.l.f. Beauty, Inc.ELF
13.0%
76.9%
99.1%
12.5%
Coty Inc. logo
Coty Inc.COTY
12.3%
10.2%
(85.0%)
1.5%
The Estée Lauder Companies Inc. logo
The Estée Lauder Companies Inc.EL
2.4%
(1.9%)
(61.2%)
2.5%

HIMS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
% growth
26.7
0.0%
82.6
209.4%
148.8
80.2%
271.9
82.8%
526.9
93.8%
872.0
65.5%
Cost of Goods Sold (COGS)18.938.039.367.4118.2157.1
Gross Profit
% margin
7.8
29.2%
44.6
54.0%
109.5
73.6%
204.5
75.2%
408.7
77.6%
714.9
82.0%
Operating Expenses83.6119.0124.6319.5477.4744.4
Research & Development Expenses (R&D)0.00.011.222.429.248.2
Selling, General & Administrative Expenses (SG&A)83.6119.0124.6319.5370.8692.7
Operating Income
% margin
(75.8)
(284.0%)
(74.4)
(90.1%)
(15.1)
(10.2%)
(115.0)
(42.3%)
(68.7)
(13.0%)
(29.5)
(3.4%)
Interest Income0.61.90.40.42.60.0
Interest Expense0.00.40.00.00.00.0
Pre-tax Income(75.2)(72.0)(18.0)(110.8)(65.7)(21.6)
Income Tax
% effective tax rate
0.0
(0.0%)
0.1
(0.1%)
0.1
(0.7%)
(3.1)
2.8%
(0.0)
0.0%
2.0
(9.2%)
Net Income
% margin
(75.2)
(282.0%)
(72.1)
(87.3%)
(18.1)
(12.2%)
(107.7)
(39.6%)
(65.7)
(12.5%)
(23.5)
(2.7%)
EPS(1.12)(2.86)(0.51)(0.58)(0.32)(0.11)
Diluted EPS(1.12)(2.86)(0.51)(0.58)(0.32)(0.11)
EBITDA
% margin
0.0
0.0%
(74.2)
(89.8%)
(14.1)
(9.5%)
(111.0)
(40.8%)
(61.2)
(11.6%)
(19.9)
(2.3%)

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Hims & Hers Health, Inc.'s EBITDA margin?

As of today, Microsoft Corp's last 12-month EBITDA margin is 4.9%, based on the financial report for Dec 31, 2024 (Q4’2024). The average annual EBITDA margin for Hims & Hers Health, Inc. have been (14.3%) over the past three years, and (23.1%) over the past five years.

2) Is Hims & Hers Health, Inc.'s EBITDA margin Good?

As of today, Hims & Hers Health, Inc.'s EBITDA margin is 4.9%, which is lower than industry median of 11.5%. It indicates that Hims & Hers Health, Inc.'s EBITDA margin is Bad.

3) How does Hims & Hers Health, Inc.'s EBITDA margin compare to its peers?

As of today, Hims & Hers Health, Inc.'s EBITDA margin is 4.9%, which is lower than peer median of 17.4%. The list of peers includes PG, CL, KVUE, UL, KMB, CHD, CLX, ELF, COTY, EL.